<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Akebia Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Akebia Therapeutics, Inc.

    We are a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with chronic kidney disease. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $302,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      John Butler
    • FOUNDED
      2007
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Accelerate Diagnostics, Inc.

    Accelerate Diagnostics, Inc.

    Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to provi...

    Accelerate Diagnostics, Inc. is an in vitro dia...

    Filing Type:    PU
    Amgen Inc.

    Amgen Inc.

    Amgen is committed to unlocking the potential of biology for patients suffering fr...

    Amgen is committed to unlocking the potential o...

    Filing Type:    PU
    Participant Assistive Products

    Participant Assistive Products

    We make affordable assistive products, starting with a groundbreaking supportive w...

    We make affordable assistive products, starting...

    Amount Raised:    $211,262.00
    Fundraising Status:    EC
    Filing Type:    CF
    Capricor Therapeutics, Inc.

    Capricor Therapeutics, Inc.

    Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology compa...

    Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a...

    Filing Type:    PU
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    Alimera Sciences, Inc.

    Alimera Sciences, Inc.

    Alimera Sciences (NASDAQ: ALIM), founded in June 2003, is a pharmaceutical company...

    Alimera Sciences (NASDAQ: ALIM), founded in Jun...

    Filing Type:    PU
    DiaMedica Therapeutics Inc.

    DiaMedica Therapeutics Inc.

    DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused ...

    DiaMedica Therapeutics Inc. is a clinical stage...

    Filing Type:    PU
    Cara Therapeutics, Inc.

    Cara Therapeutics, Inc.

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Cara Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    Opko Health, Inc.

    Opko Health, Inc.

    OPKO Health, Inc. is a diversified healthcare company that seeks to serve unmet pa...

    OPKO Health, Inc. is a diversified healthcare c...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.